Altimmune (ALT) Current Leases (2020 - 2026)
Altimmune (ALT) reported Current Leases of $265000.0 for Q1 2026, up 8.16% year-over-year from $245000.0 in Q1 2025, and up 3.52% quarter-over-quarter from $256000.0 in Q4 2025.
Altimmune (ALT) Current Leases (2020 - 2026) Analysis & Trends
Altimmune (ALT) has 7 years of Current Leases data on file, last reported at $265000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $265000.0, up 8.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $265000.0 (up 8.16% YoY), and the FY2025 annual result was $256000.0, down 8.24% from the prior year.
- Current Leases rose to $265000.0 in Q1 2026 per ALT's latest filing, from $256000.0 in the prior quarter.
- Over five years, Current Leases peaked at $508000.0 in Q1 2024 and troughed at $239000.0 in Q2 2025.
- A 5-year average of $374176.5 and a median of $421000.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2025: Current Leases climbed 9.98% in 2023, then tumbled 51.77% in 2025.
- A 5-year view of Current Leases shows it stood at $452000.0 in 2022, then advanced by 9.73% to $496000.0 in 2023, then plunged by 43.75% to $279000.0 in 2024, then fell by 8.24% to $256000.0 in 2025, then advanced by 3.52% to $265000.0 in 2026.
- Business Quant data shows ALT's Current Leases at $265000.0 in Q1 2026, $256000.0 in Q4 2025, and $247000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | 265,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 265,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 247,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 245,000.00 |
| Dec 31, 2024 | 279,000.00 |
| Sep 30, 2024 | 313,000.00 |
| Jun 30, 2024 | 345,000.00 |
| Mar 31, 2024 | 508,000.00 |
| Dec 31, 2023 | 496,000.00 |
| Sep 30, 2023 | 485,000.00 |
| Jun 30, 2023 | 474,000.00 |
| Mar 31, 2023 | 463,000.00 |
| Dec 31, 2022 | 452,000.00 |
| Sep 30, 2022 | 442,000.00 |
| Jun 30, 2022 | 431,000.00 |
| Mar 31, 2022 | 421,000.00 |
| Dec 31, 2021 | 411,000.00 |
| Dec 31, 2020 | 356,716.00 |